Sorrento Therapeutics Inc (SRNE)

[1776club]

Yup, agree with all of that, especially you not being Virginia (lol). Thinking that revenues from early sales may not have made 3rd Q cutoff or have been delayed in posting to show a larger revenue from CoviStix in the 4th Q. Not that I have ever seen that happen...cough, cough.
I do wonder if Sorrento has it in them to open the kimono, clear away the cobwebs and give clarity to no EUA from the US after more than a year and a look at the future revenue stream here and abroad. Sorrento has its tentacles in a lot of countries. Where do we stand with Dyadic as far as the use of their technology (since Sorrento has invested time and money in a vaccine using C1), lot of insider sales in Dyadic at the time of two spikes, going forward; broad, limited or out of the money.
In short where is their Best Few for this year and next. Surely they can do that for the gallery.